Xencor | XNCR - Stammkapital





Stammkapital Veränderung Datum
AbbVie USD 1.77B 1.75B 2025-06
Alnylam Pharmaceuticals USD 133.44M 1.07M 2026-03
Amgen USD 540M 1000K 2026-03
Arrowhead Research USD 135.7M 2.44M 2025-09
AstraZeneca USD 1.55B 73K 2026-03
Biogen USD 146.7M 200K 2025-09
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Cytokinetics USD 122.26M 145K 2025-12
GlaxoSmithKline GBP 4.05B 20.6M 2026-03
J&J USD 2.41B 1.74M 2025-12
Karyopharm Therapeutics USD 18.31M 18.3M 2025-12
MacroGenics USD 63.32M 60K 2025-12
Merck USD 2.47B 12.72M 2025-12
Novartis USD 1.91B 60K 2026-03
Pfizer USD 5.69B 0 2025-12
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Roche Holding CHF 795.62M 699.54K 2025-12
Xencor USD 71.87M 529K 2025-12